Vapendavir

N/A

Report date: 2024/03/15 20:05:13
NME

Base Information

Drug NameVapendavir
Drug Alias NameVapendavirum伐喷达韦伐彭达韦BTA-798
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitorsVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsRhinovirus infectionLower Respiratory Tract InfectionsEmphysema +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAviragen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAltesa Biosciences Inc
Inactive CompaniesVaxart IncAviragen Therapeutics IncBiota Scientific Management Pty Ltd
Active IndicationsRhinovirus infectionLower Respiratory Tract InfectionsEmphysema +[10] 
Inactive IndicationsAsthmaRespiratory Tract DiseasesInfections

Other Information

ATC CodeN/A
Related LinksN/A